![Maria Dul](https://profiles-cardiff.imgix.net/attachments/2911?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Maria Dul
Teams and roles for Maria Dul
Post Doctoral Research Associate
Overview
PDRA with Prof James Birchall
Publication
2026
- Weimer, P. et al., 2026. Development of dissolving microneedles using a quality by design approach for transdermal delivery of the nanoemulsified volatile compound β-caryophyllene. International Journal of Pharmaceutics 691 126616. (10.1016/j.ijpharm.2026.126616)
2025
- Dul, M. et al. 2025. White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin. Journal of Controlled Release 378 , pp.402-415. (10.1016/j.jconrel.2024.11.056)
2023
- Dul, M. et al. 2023. Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product. Journal of Controlled Release 361 , pp.236-245. (10.1016/j.jconrel.2023.07.001)
2021
- Ingrole, R. S. et al., 2021. Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity. Biomaterials 267 120491. (10.1016/j.biomaterials.2020.120491)
2019
- Dul, M. et al. 2019. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy. International Journal of Pharmaceutics 562 , pp.303-312. (10.1016/j.ijpharm.2019.03.041)
2018
- Slatter, D. A. et al. 2018. Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies. JCI Insight 3 (6) e98459. (10.1172/jci.insight.98459)
2017
- Dul, M. et al. 2017. Hydrodynamic gene delivery in human skin using a hollow microneedle device. Journal of Controlled Release 265 , pp.120-131. (10.1016/j.jconrel.2017.02.028)
Articles
- Weimer, P. et al., 2026. Development of dissolving microneedles using a quality by design approach for transdermal delivery of the nanoemulsified volatile compound β-caryophyllene. International Journal of Pharmaceutics 691 126616. (10.1016/j.ijpharm.2026.126616)
- Dul, M. et al. 2025. White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin. Journal of Controlled Release 378 , pp.402-415. (10.1016/j.jconrel.2024.11.056)
- Dul, M. et al. 2023. Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product. Journal of Controlled Release 361 , pp.236-245. (10.1016/j.jconrel.2023.07.001)
- Ingrole, R. S. et al., 2021. Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity. Biomaterials 267 120491. (10.1016/j.biomaterials.2020.120491)
- Dul, M. et al. 2019. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy. International Journal of Pharmaceutics 562 , pp.303-312. (10.1016/j.ijpharm.2019.03.041)
- Slatter, D. A. et al. 2018. Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies. JCI Insight 3 (6) e98459. (10.1172/jci.insight.98459)
- Dul, M. et al. 2017. Hydrodynamic gene delivery in human skin using a hollow microneedle device. Journal of Controlled Release 265 , pp.120-131. (10.1016/j.jconrel.2017.02.028)